Personal information

Countries

New Zealand

Activities

Collapse all

Employment (2)

Malaghan Institute of Medical Research: Wellington, NZ

2018-09 to present | Research Officer
Employment
Source: Self-asserted source
Tara Pritchard

Children's Cancer Institute Australia: Randwick, New South Wales, AU

2015-10 to 2018-08 | Research Assistant
Employment
Source: Self-asserted source
Tara Pritchard

Education and qualifications (1)

University of Otago: Dunedin, NZ

2014-01 to 2015-02 | Masters Degree (Pharmacology and Toxicology)
Education
Source: Self-asserted source
Tara Pritchard

Works (6)

Data from OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527832
Contributors: Kathryn Evans; JianXin Duan; Tara Pritchard; Connor D. Jones; Lisa McDermott; Zhaohui Gu; Cara E. Toscan; Narimanne El-Zein; Chelsea Mayoh; Stephen W. Erickson et al.
Source: check_circle
Crossref

Data from OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6527832.v1
Contributors: Kathryn Evans; JianXin Duan; Tara Pritchard; Connor D. Jones; Lisa McDermott; Zhaohui Gu; Cara E. Toscan; Narimanne El-Zein; Chelsea Mayoh; Stephen W. Erickson et al.
Source: check_circle
Crossref

Supplementary Data from OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22471269
Contributors: Kathryn Evans; JianXin Duan; Tara Pritchard; Connor D. Jones; Lisa McDermott; Zhaohui Gu; Cara E. Toscan; Narimanne El-Zein; Chelsea Mayoh; Stephen W. Erickson et al.
Source: check_circle
Crossref

Supplementary Data from OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22471269.v1
Contributors: Kathryn Evans; JianXin Duan; Tara Pritchard; Connor D. Jones; Lisa McDermott; Zhaohui Gu; Cara E. Toscan; Narimanne El-Zein; Chelsea Mayoh; Stephen W. Erickson et al.
Source: check_circle
Crossref

Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor

Journal of Drug Targeting
2019-09-14 | Journal article
DOI: 10.1080/1061186X.2019.1566341
Contributors: Khaled Greish; Hayley Nehoff; Fatemah Bahman; Tara Pritchard; Sebastien Taurin
Source: check_circle
Crossref

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

Clinical Cancer Research
2019-07-15 | Journal article
DOI: 10.1158/1078-0432.CCR-19-0551
Contributors: Kathryn Evans; JianXin Duan; Tara Pritchard; Connor D. Jones; Lisa McDermott; Zhaohui Gu; Cara E. Toscan; Narimanne El-Zein; Chelsea Mayoh; Stephen W. Erickson et al.
Source: check_circle
Crossref
How many people are using ORCID?